Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1988 4
1989 4
1990 4
1993 1
1994 1
1997 1
1998 3
1999 3
2000 7
2001 14
2002 11
2003 12
2004 14
2005 24
2006 24
2007 19
2008 26
2009 30
2010 16
2011 28
2012 18
2013 18
2014 15
2015 16
2016 7
2017 6
2018 13
2019 13
2020 21
2021 9
2022 12
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

356 results

Results by year

Filters applied: . Clear all
Page 1
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma.
Powles T, Park SH, Voog E, Caserta C, Valderrama BP, Gurney H, Kalofonos H, Radulović S, Demey W, Ullén A, Loriot Y, Sridhar SS, Tsuchiya N, Kopyltsov E, Sternberg CN, Bellmunt J, Aragon-Ching JB, Petrylak DP, Laliberte R, Wang J, Huang B, Davis C, Fowst C, Costa N, Blake-Haskins JA, di Pietro A, Grivas P. Powles T, et al. Among authors: kalofonos h. N Engl J Med. 2020 Sep 24;383(13):1218-1230. doi: 10.1056/NEJMoa2002788. Epub 2020 Sep 18. N Engl J Med. 2020. PMID: 32945632 Clinical Trial.
Avelumab First-line Maintenance Therapy for Advanced Urothelial Carcinoma: Comprehensive Clinical Subgroup Analyses from the JAVELIN Bladder 100 Phase 3 Trial.
Grivas P, Park SH, Voog E, Caserta C, Gurney H, Bellmunt J, Kalofonos H, Ullén A, Loriot Y, Sridhar SS, Yamamoto Y, Petrylak DP, Sternberg CN, Gupta S, Huang B, Costa N, Laliberte RJ, di Pietro A, Valderrama BP, Powles T. Grivas P, et al. Among authors: kalofonos h. Eur Urol. 2023 Jul;84(1):95-108. doi: 10.1016/j.eururo.2023.03.030. Epub 2023 Apr 28. Eur Urol. 2023. PMID: 37121850 Free article. Clinical Trial.
In Reply.
Papachristos A, Kemos P, Kalofonos H, Sivolapenko G. Papachristos A, et al. Among authors: kalofonos h. Oncologist. 2020 Dec;25(12):e2023. doi: 10.1002/onco.13565. Epub 2020 Oct 26. Oncologist. 2020. PMID: 33044037 Free PMC article.
Radiotherapy and Renal Cell Carcinoma: A Continuing Saga.
Spyropoulou D, Tsiganos P, Dimitrakopoulos FI, Tolia M, Koutras A, Velissaris D, Lagadinou M, Papathanasiou N, Gkantaifi A, Kalofonos H, Kardamakis D. Spyropoulou D, et al. Among authors: kalofonos h. In Vivo. 2021 May-Jun;35(3):1365-1377. doi: 10.21873/invivo.12389. Epub 2021 Apr 28. In Vivo. 2021. PMID: 33910814 Free PMC article. Review.
Molecular Epidemiology and Treatment Patterns of Patients With EGFR Exon 20-Mutant NSCLC in the Precision Oncology Era: The European EXOTIC Registry.
Mountzios G, Planchard D, Metro G, Tsiouda D, Prelaj A, Lampaki S, Shalata W, Riudavets M, Christopoulos P, Girard N, Albarrán-Artahona V, Garcia Campelo R, Samitas K, Banna GL, Boukovinas I, Agbarya A, Koumarianou A, Perdikouri EI, Kosmidis P, Linardou H, Mauri D, Mavroudis D, Athanasiadis I, Kalofonos H, Xenidis N, Korantzis I, Ardavanis A, Rallis G, Bottiglieri A, Efthymiadis K, Oikonomopoulos G, Kokkalis A, Saloustros E, Tsoukalas N, Bartzi D, Economopoulou P, Psyrri A, Reck M, Lo Russo G. Mountzios G, et al. Among authors: kalofonos h. JTO Clin Res Rep. 2022 Nov 20;4(1):100433. doi: 10.1016/j.jtocrr.2022.100433. eCollection 2023 Jan. JTO Clin Res Rep. 2022. PMID: 36793384 Free PMC article.
Bortezomib-induced peripheral neurotoxicity: an update.
Argyriou AA, Cavaletti G, Bruna J, Kyritsis AP, Kalofonos HP. Argyriou AA, et al. Among authors: kalofonos hp. Arch Toxicol. 2014 Sep;88(9):1669-79. doi: 10.1007/s00204-014-1316-5. Epub 2014 Jul 29. Arch Toxicol. 2014. PMID: 25069804 Review.
Anti-PD-1 associated retroperitoneal fibrosis.
Daoussis D, Kraniotis P, Kalofonou F, Kalofonos H. Daoussis D, et al. Among authors: kalofonos h. Rheumatology (Oxford). 2021 Sep 1;60(9):e329-e330. doi: 10.1093/rheumatology/keab264. Rheumatology (Oxford). 2021. PMID: 33729466 No abstract available.
Cardiovascular effects of treatment with taxanes.
Peroukides S, Alexopoulos A, Kalofonos H, Papadaki H. Peroukides S, et al. Among authors: kalofonos h. J Cardiovasc Med (Hagerstown). 2012 May;13(5):319-24. doi: 10.2459/JCM.0b013e3283529060. J Cardiovasc Med (Hagerstown). 2012. PMID: 22476001 Review.
The Fire Within: NF-κB Involvement in Non-Small Cell Lung Cancer.
Dimitrakopoulos FD, Kottorou AE, Kalofonou M, Kalofonos HP. Dimitrakopoulos FD, et al. Among authors: kalofonos hp. Cancer Res. 2020 Oct 1;80(19):4025-4036. doi: 10.1158/0008-5472.CAN-19-3578. Epub 2020 Jul 2. Cancer Res. 2020. PMID: 32616502 Review.
356 results